Medical News

RSS

New radiation technique to treat cancer that has spread to the brain prevents hair loss

Patients whose cancer has spread to the brain can avoid typical hair loss (alopecia) when treated with newer radiation techniques, thereby improving their quality of life while still controlling their cancer, according to a study presented October 16, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.

16 Oct 2005

dnaJP1 - novel drug for the treatment of rheumatoid arthritis

Researchers at the University of California, San Diego (UCSD) School of Medicine have announced successful completion of Phase II clinical trials of a novel drug for the treatment of rheumatoid arthritis (RA), one that works without suppressing the patient's immune system.

16 Oct 2005

Research reveals concerns over use of health information

New Economic & Social Research Council (ESRC) funded research has discovered that eight per cent of people are asked to pay a higher premium because of health 'ratings' - twice as many as previously thought.

16 Oct 2005

Ethnic differences in cardiovascular risk factors

Heredity plays a major role in determining the blood lipid profile and heart rate variability of blacks and whites, two major risk factors for coronary artery disease, researchers say.

16 Oct 2005

Gene therapy may prevent the damaging effects of radiation

Gene therapy could be used as an agent to protect normal tissues, including the esophagus and lung, from damage during a second administration of radiation therapy for non-small cell lung cancer, according to an animal study presented by University of Pittsburgh researchers at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

16 Oct 2005

High blood pressure is higher in many Asian countries than in Australia

A new study on risk factors in cardiovascular disease in Asia has found that blood pressure is more strongly related to coronary heart disease and stroke in Asia, as compared with Western countries such as Australia and New Zealand.

16 Oct 2005

Computer-assisted instruction offers the potential to overcome knowledge barriers and improve screening rates

Even patients with minimal education and no computer skills can be successfully educated about health topics using computers, according to new research at Wake Forest University Baptist Medical Center.

16 Oct 2005

Curry spice appears to shut down a protein active in the spread of breast cancer

Curcumin, the main ingredient of turmeric and the compound that gives curry its mustard-yellow color, inhibits metastasis to the lungs of mice with breast cancer, report researchers at The University of Texas M. D. Anderson Cancer Center

16 Oct 2005

Strain of avian influenza highly resistant to Tamiflu

An avian influenza virus isolated from an infected Vietnamese girl has been determined to be resistant to the drug oseltamivir, the compound better known by its trade name Tamiflu, and the drug officials hope will serve as the front line of defense for a feared influenza pandemic.

16 Oct 2005

Possible explanation for the higher incidence of lung cancer in African Americans

Faulty cell cycle "checkpoints" that fail to respond to DNA damage effectively may contribute to the high incidence of lung cancer in African-Americans, say researchers at Georgetown University's Lombardi Comprehensive Cancer Center and the National Cancer Institute (NCI).

16 Oct 2005

Fungal contamination of bedding

Researchers at The University of Manchester funded by the Fungal Research Trust have discovered millions of fungal spores right under our noses - in our pillows.

From The University of Manchester 16 Oct 2005

Isotretinoin-related birth defects

Isotretinoin (also known as Accutane) is a drug used to treat severe acne, but it can cause birth defects when taken by pregnant women. Because of these risks, the U.S. Food and Drug Administration and Roche Pharmaceuticals (Accutane's manufacturer) developed a voluntary pregnancy prevention program (PPP) in 1988 to try and prevent conception in women taking the drug.

16 Oct 2005

Family history of alcohol dependency does not relate to age of first drink

Having a first alcoholic drink at the early age of 12, 13 or 14 might be influenced more by a child's tendency to do things like lie, steal or skip school than by a family history of alcohol dependency, according to findings by University of Iowa and other investigators.

16 Oct 2005

Researchers find new type of antibiotic against the cholera bacteria

Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria.

16 Oct 2005

Discovery could help make cellular immunotherapy safer

Researchers at the University of Michigan's Comprehensive Cancer Center have discovered the secret weapon behind the most powerful form of cancer immunotherapy known to medicine.

16 Oct 2005

Aggressive management of diabetes with diet, exercise, and medications may improve the survival of cancer patients

Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.

16 Oct 2005

Cell phones speed heart attack treatment

A Michigan hospital has cut in half the time it takes to begin life-saving treatment of heart attack patients by using cell phones to transmit electrocardiograms (ECGs) from the field

16 Oct 2005

Largest known series of data examining the sequencing of tamoxifen and radiation

Fox Chase Cancer Center researchers say the sequence of tamoxifen and radiation following lumpectomy for early-stage breast cancer patients does not affect disease control, survival or complication rates, but administering tamoxifen concurrently with radiation has negative cosmetic results.

16 Oct 2005

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

The Committee for Medicinal Products for Human Use (CHMP) has announced its decision to extend Ebixa’s current indication (moderately severe to severe disease) to include moderate stages of Alzheimer’s disease (AD).

16 Oct 2005

E-cadherin, that cellular touch so important in cancer

E-cadherin is a molecule involved in adhesion between epithelial cells that also seems to have a protective role in cancer, since its loss is associated with tumour progression and metastases formation in a series of different cancers.

16 Oct 2005